Back to VA VANGUARD CAPITAL MANAGEMENT LLC
TRAW2 quarters
Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in TRAWS PHARMA INC
Yes. Vanguard Capital Management holds 330,049 shares of TRAW (Traws Pharma), worth $278,231, as of its Q2 2026 13F filing. It increased the position from 55,193 shares in Q1 2026. Vanguard Capital Management has held TRAW in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$278,231
Current Shares
330,049
Total Value Change
+$177,228
Total Shares Change
+274,856
Quarter-by-Quarter History
Other major holders of TRAW: ADAGE CAPITAL PARTNERS GP, L.L.C., Alyeska Investment Group, L.P.